Related Experiment Video
Updated: Aug 8, 2026
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
[Effect of RNA interference on EGF receptor expression of non-small-cell lung cancer A549 cell line]
Min Zhang1, Xin Zhang, Chun-xue Bai
1Department of Pulmonary Disease, Fudan University, Shanghai 200032, China.
Objective:
To investigate changes in biologic properties of non-small-cell lung cancer (NSCLC) A549 cells whose EGF receptor (EGFR) expression was suppressed by short interference RNA (siRNA).
Methods:
A549 cells were transfected with synthetic EGFR sequence-specific siRNA by Lipofectamine. EGFR expression was examined by Western blot and flow cytometry. The biological features of the transfected A549 cells were assessed by cell cycle analysis, colony formation and chemosensitivity assay.
Results:
Sequence-specific siRNAs targeting EGFR significantly down-regulated its expression in A549 cells. Cell growth and colony formation were inhibited by 85.0% and 63.3%, respectively, as compared to the non-sequence-specific siRNA treated cells. Decreased EGFR expression was accompanied by 12.7% increase in A549 cells in G(0)-G(1) phase and 6.6% decrease in S-phase. The EGFR sequence-specific siRNA transfected A549 cells were much more sensitive to the cytotoxic effect of cisplatin with a 77.2% decrease in IC(50) compared to the non-sequence-specific iRNA transfected A540 cells.
Conclusion:
Down regulation of EGFR expression of NSCLC by sequence-specific siRNA may be considered as an additional option in the treatment of EGFR over-expressing cancers, including NSCLC.
Insights
Short interference RNA (siRNA) targeting the epidermal growth factor receptor (EGFR) suppressed EGFR expression in non-small-cell lung cancer cells. This suppression inhibited cell growth and increased sensitivity to chemotherapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Non-small-cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
- Epidermal growth factor receptor (EGFR) is frequently overexpressed in NSCLC and drives tumor growth.
- Targeting EGFR is a key strategy in NSCLC treatment.
Purpose of the Study:
- To investigate the biological effects of suppressing EGFR expression in NSCLC A549 cells using short interference RNA (siRNA).
Main Methods:
- A549 cells were transfected with EGFR-specific siRNA.
- EGFR expression levels were analyzed using Western blot and flow cytometry.
- Cell cycle progression, colony formation, and chemosensitivity to cisplatin were evaluated.
Main Results:
- EGFR-specific siRNA significantly reduced EGFR expression in A549 cells.
- Cell proliferation and colony formation were markedly inhibited (85.0% and 63.3%, respectively).
- Cells exhibited increased G0-G1 phase arrest (12.7%) and enhanced sensitivity to cisplatin (77.2% decrease in IC50).
Conclusions:
- Downregulation of EGFR via siRNA effectively inhibits NSCLC cell growth and enhances chemosensitivity.
- EGFR-targeted siRNA represents a potential therapeutic strategy for EGFR-overexpressing NSCLC.
Related Concept Videos
01:23RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
02:38Mitogens and the Cell Cycle